Searched over 200M research papers
7 papers analyzed
These studies suggest that serum ferritin is the most powerful test for diagnosing iron-deficiency anemia, with additional methods like the AMPS test, routine blood tests, and reticulocyte hemoglobin content also providing valuable diagnostic information, especially in specific populations or settings.
19 papers analyzed
Serum ferritin is widely recognized as the most powerful test for diagnosing iron-deficiency anemia (IDA). It measures the stored iron in the body, providing a clear indication of iron levels. Studies have shown that serum ferritin radioimmunoassay has an area under the receiver operating characteristic curve (AUC) of 0.95, making it highly reliable. This test is particularly effective across various patient populations, including those with inflammatory, liver, or neoplastic diseases.
A complete blood count (CBC) is another essential test for diagnosing IDA. It examines red blood cells (RBCs) for characteristics such as size (mean corpuscular volume, MCV) and hemoglobin content (mean corpuscular hemoglobin concentration, MCHC). IDA typically presents with microcytic (small) and hypochromic (pale) RBCs. The CBC is a routine test that can be performed using a hematology analyzer, although these machines are often expensive and require trained personnel.
Routine blood tests, including measurements of hemoglobin (Hb), MCV, MCHC, red blood cell distribution width (RDW), and the percentage of low hemoglobin density (LHD), are valuable for screening iron deficiency in children. Studies have shown that MCV, RDW, and MCHC have higher sensitivity for detecting iron deficiency compared to hemoglobin alone. For instance, MCV values below 80.2 fL, RDW above 0.131, and MCHC below 322 g/L are indicative of iron deficiency.
Iron levels and related laboratory values can change with age. Data from the Second National Health and Nutrition Examination Survey (NHANES II) highlight the importance of considering age-related changes when diagnosing anemia and iron deficiency. Median values and 95% ranges for various tests, including Hb, hematocrit, and transferrin saturation, vary significantly across different age groups. This variability must be accounted for to accurately identify individuals with iron deficiency.
In elderly patients, serum ferritin remains the best test for diagnosing iron deficiency. A study involving anemic patients over 65 years old found that serum ferritin levels below 18 micrograms/L significantly increase the likelihood of iron deficiency, while levels above 100 micrograms/L decrease it. This test outperforms others like mean cell volume (MCV) and transferrin saturation in this age group.
The reticulocyte hemoglobin content (CHr) is an early indicator of functional iron deficiency. Reticulocytes are the youngest red blood cells, and their hemoglobin content reflects recent iron availability. CHr has been shown to have high sensitivity and specificity for predicting the absence of bone marrow iron stores, especially when excluding patients with high MCV or red cell disorders.
The ironPhone is a novel, mobile device-coupled diagnostic tool for assessing iron status by quantifying serum ferritin. This portable system uses a smartphone accessory, an app, and a disposable test strip to measure ferritin levels from a drop of blood. Initial validations have shown a high correlation with standard laboratory methods, making it a promising tool for point-of-care diagnostics, especially in low-resource settings.
Understanding blood test results for iron levels involves interpreting various indicators, with serum ferritin being the most reliable for diagnosing iron-deficiency anemia. Routine blood tests, age-related changes, and innovative diagnostic tools like the ironPhone enhance the accuracy and accessibility of iron status assessments. These advancements are crucial for timely and effective diagnosis and management of iron deficiency across different populations.
Most relevant research papers on this topic